Mabion S.A. (WSE:MAB)
Poland · Delayed Price · Currency is PLN 7.98
+0.01 (0.13%)
Oct 15, 2026, 11:05 AM CET
Mabion Market Cap
Mabion has a market cap or net worth of 128.98 million as of October 14, 2026. It is the 33,421st most valuable company in the world and the 243rd biggest in Poland. Its market cap has decreased by 5.90% in one year.
Market Cap
128.98M
Enterprise Value
155.62M
Revenue
17.61M
Global Rank
Country Rank
#243 Poland
PE Ratio
n/a
ChartMarket Cap Chart
Since August 10, 2010, Mabion's market cap has increased from 93.01M to 128.98M, an increase of 38.67%. That is a compound annual growth rate of 2.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 128.98M | 14.33% |
| Dec 30, 2025 | 112.81M | -21.57% |
| Dec 30, 2024 | 143.84M | -50.96% |
| Dec 29, 2023 | 293.35M | -13.57% |
| Dec 30, 2022 | 339.41M | -65.63% |
| Dec 30, 2021 | 987.46M | 246.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ryvu Therapeutics | 394.89M |
| Bioceltix | 386.15M |
| Captor Therapeutics Spolka Akcyjna | 378.66M |
| BIOTON | 325.00M |
| Synthaverse | 211.40M |
| Molecure | 134.74M |
| Poltreg | 119.51M |
| NanoGroup | 101.88M |